SCHEMBL6948651

SCHEMBL6948651

O=C(O)c1ccc(-c2c[nH]c3ccccc23)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAMKK2 Q96RR4 2/20 0.60
NR4A2 P43354 1/20 0.60
IMPDH2 P12268 2/20 0.56
MAPK1 P28482 1/20 0.56
HSD17B10 Q99714 1/20 0.56
AXL P30530 2/20 0.55
SGK1 O00141 1/20 0.55
MAP2K4 P45985 1/20 0.54
BRD4 O60885 1/20 0.51
GPR84 Q9NQS5 2/20 0.50
ASH1L Q9NR48 1/20 0.50
GAA P10253 1/20 0.50
CASP3 P42574 1/20 0.50
KLF5 Q13887 1/20 0.50
SENP8 Q96LD8 1/20 0.50
SENP7 Q9BQF6 1/20 0.50
SENP6 Q9GZR1 1/20 0.50
PDE10A Q9Y233 1/20 0.49
TDO2 P48775 1/20 0.48
SIRT2 Q8IXJ6 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27698578 0.85 NR4A2 (0.58) NR4A2IMPDH2MAPK1HSD17B10SGK1
SCHEMBL28377762 0.84 NR4A2 (0.81) NR4A2IMPDH2MAPK1HSD17B10ASH1L
SCHEMBL29221047 0.83 PTPN1 (0.62) CAMKK2NR4A2IMPDH2AXLSGK1
SCHEMBL22044149 0.82 PTPN1 (0.59) NR4A2AXL
SCHEMBL5424839 0.82 PTPN1 (0.61) BRD4GPR84ASH1LGAACASP3
SCHEMBL29221014 0.82 PTPN1 (0.61) CAMKK2AXLSGK1ASH1L
SCHEMBL179165 0.82 PTPN1 (0.61) CAMKK2IMPDH2AXLSGK1ASH1L
SCHEMBL5429419 0.82 PTPN1 (0.61) BRD4GPR84ASH1LGAACASP3
SCHEMBL28416622 0.82 NR4A2 (0.78) NR4A2IMPDH2MAPK1HSD17B10ASH1L
3-Phenylindole SCHEMBL84056 0.82 IMPDH2 (0.71) NR4A2IMPDH2MAPK1HSD17B10ASH1L

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250179046-A1 SEROTONIN 5-HT2B INHIBITORY COMPOUNDS ZOETIS SERVICES LLC 2025-06-05 US disclosed
CN-113631548-B Serotonin 5-HT2B inhibiting compounds 硕腾服务有限责任公司 2023-06-06 CN disclosed
EP-3947360-A1 SEROTONIN 5-HT2B INHIBITORY COMPOUNDS Zoetis Services LLC (US) 2022-02-09 EP disclosed
CN-113631548-A Serotonin 5-HT2B inhibiting compounds 硕腾服务有限责任公司 2021-11-09 CN disclosed
WO-2020198478-A1 SEROTONIN 5-HT2B INHIBITORY COMPOUNDS ZOETIS SERVICES LLC (US) 2020-10-01 WO disclosed
EP-1354887-A1 Ligands for metals and improved metal-catalyzed processes based thereon Massachusetts Insitute of Technology (US) 2003-10-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250179046-A1 SEROTONIN 5-HT2B INHIBITORY COMPOUNDS HTR2B, HTR1B, HTR5A CAMKK2 2465/4885NR4A2 1632/4885IMPDH2 2064/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.